Guided Modified Socket Shield With Hyaluronic Acid for Black Triangle Management

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-50
SponsorKafrelsheikh University

About this trial

The Primary aim of this study will be to evaluate the clinical, esthetic, and radiographic outcomes of hyaluronic acid combined with immediate implant placement using AI-assisted and computer guided modified socket shield technique in maxillary anterior sites exhibiting black triangles.

Eligibility criteria

Qualifiers

Adults (20-50) years old.

Single rooted maxillary anterior teeth with hopeless prognosis.

Periodontally compromised but with >50% remaining bone.

Presence of black triangle ≥2 mm.

Disqualifiers

Medically compromised patients and systemic conditions that complicate implant placement as uncontrolled diabetes, osteoporosis.

Alcoholic and Smokers patients.

Pregnant or lactating women.

Acute Pathology or infection at implant site

Trial design

Treatments tested in this trial

  • Guided socket shield without Hyaluronic acid
  • Guided socket shield with hyaluronic acid

Treatment groups

32 Participants
are divided into 2 treatment groups

Sponsors and collaborators